Everything You Need to Know About CBD: Medical Advice and Legislation in Switzerland

understanding the costs of medical cannabis
Cannabis legalization
25.05.26

In Switzerland, a CBD product is permitted and available over the counter if it contains less than 1% tetrahydrocannabinol (THC) and is not marketed as a medicine. The Federal Act on the Control of Narcotics (LDAl) and the Federal Act on Medicines (LPTh) establish this framework, which is distinct from that governing recreational cannabis. This article explains the definition of cannabidiol, how it differs from THC, current Swiss legislation, precautions to take before making a purchase, and specific quality criteria to check for in a product.

Key takeaways

What is CBD?

Definition and Origin of Cannabidiol

Cannabidiol (CBD) is a cannabinoid molecule that occurs naturally in hemp. It is one of the plant’s many components, alongside other cannabinoids and terpenes. In everyday language, “CBD” also refers to products that contain it—oil, balm, tea, flowers, resins—depending on the format and category.

In Switzerland, this basic definition is not sufficient to determine whether a product can be sold. The way CBD is incorporated into the formula, its labeling, its category (cosmetics, herbal tea, etc.), and its compliance with the legal framework are just as important as the molecule itself. It is the combination of these factors that determines whether a product is authorized, and under what conditions.

A useful guideline: you can discuss usage and experience, but not treatment claims or medical efficacy. This isn’t just a stylistic detail—it’s a legal requirement.

The Difference Between CBD and THC

Tetrahydrocannabinol (THC) is the compound responsible for the psychoactive effects of cannabis. CBD, on the other hand, is not sought after for those effects.

This distinction is key in Switzerland, as the THC level determines whether the product complies with regulations:

Two “hemp-based” products can therefore be treated very differently: one is compliant, while the other is subject to a recall or ban. When discussing risks, the conversation also centers on compliance, transparency, and the clarity of the information provided at the time of sale.

CBD Legislation in Switzerland: Current Framework

Approved products and non-compliant products

Swiss legislation regarding CBD depends on four factors: the type of product, its composition (particularly THC), its intended use, and its commercial presentation. Some products are permitted within a specific framework; other formats or presentations may be deemed non-compliant, which effectively amounts to a ban on their sale.

A key distinction: as soon as a product is marketed as a drug or is intended for therapeutic use, it falls into a different category and is subject to different regulatory requirements (Swissmedic authorization framework requiring a prescription). That is why responsible communication in Switzerland remains factual: informing and describing a use—yes; promising a cure—no.

Changes in the Legal Framework

The CBD market has become more structured, and the Swiss regulatory framework has become clearer over the years, covering composition, labeling, testing, and product categories. Regulations continue to be refined in line with decisions and policy statements issued by federal authorities.

In practical terms, when making a purchase, there are two simple steps to follow:

  1. Verify that the product is clearly positioned (category, intended use, compliance).
  2. Prioritize transparent suppliers: hemp origin, laboratory analyses, traceability, and quality controls.

Medical opinion: what the Swiss guidelines say

When you search for “CBD” and “medical advice,” you come across some very strong claims. To make sense of this, it’s important to distinguish between three areas: what research is exploring, what falls under wellness use, and what might be considered medical use under a doctor’s supervision, with a view to treatment that involves a prescription and the dispensing of medication.

In other words: referring to “medical effects” does not mean that an over-the-counter CBD product can claim to have therapeutic efficacy. Swiss regulations strictly govern what claims can be made and what constitutes a violation of the ban on therapeutic claims.

Prescription vs. over-the-counter 

In practice, there are two distinct realities:

This approach protects consumers and prevents wellness products from being mistaken for medications.

Read the claims on over-the-counter products with caution

When it comes to sensitive topics (how you feel at the end of the day, moments of stress, how you feel after exercise), caution is essential. Claiming that a product “treats” anything constitutes an unauthorized medical claim. 

Responsible reading involves:

Key takeaway – A PubMed study does not automatically turn a product into a medication, and a testimonial does not prove universal effectiveness. These sources help provide context; they are not a substitute for professional advice.

Risks and Precautions

Like any active ingredient, CBD can carry risks. The goal is not to alarm you, but to provide guidance for safer use—especially if you are already undergoing medical treatment.

Possible side effects

Depending on the individual, sensitivity, and dosage, side effects may occur, such as fatigue, drowsiness, digestive discomfort, or a dry mouth. These are possible side effects, not a universal rule.

Two good habits to keep in mind before buying an over-the-counter CBD product:

CBD and Interactions with Other Medications 

This is the most important point: CBD can interact with certain medications. If you’re considering adding an over-the-counter CBD product to your routine, consulting a doctor or pharmacist beforehand is the safest approach.

How do you choose a high-quality CBD product?

In Switzerland, the quality of a CBD product isn’t just about how it makes you feel. It depends on regulatory compliance, transparency regarding its ingredients (particularly tetrahydrocannabinol), and how the product is marketed. A worry-free purchase starts with an informed one.

Five quality criteria to check

CriterionWhat to Watch
Laboratory analyses (COA)Recent, readily available test results confirming the CBD and THC content
Hemp traceabilityOrigin, cultivation method, batch, documented tracking
Clear compositionClear ingredient list, usage instructions, and precautions
Category and labelingProduct category and presentation aligned with the Swiss framework
Responsible CommunicationFactual information; no guarantees of effectiveness

Choose a transparent Swiss supplier

Rather than a fixed ranking, good Swiss suppliers can be identified by four verifiable indicators:

To help you get started with confidence, the Naturalpes line of CBD oils Naturalpes entirely made in Switzerland, full-spectrum, and comes with batch analysis reports. The CBD Wellness Pack includes a 20% wellness oil, a hemp tea, and a body balm: a trio designed to help you gradually discover a pampering routine, 100% Swiss-made, featuring hemp that is hand-harvested and hand-dried. It’s a natural way to incorporate CBD into your daily life without having to make multiple separate purchases.

Read reviews and recommendations

Opinions on CBD are everywhere. The key is to know how to weigh them: personal experiences can help inform a decision, but they are neither scientific proof nor a guarantee of effectiveness. When it comes to “medical advice,” caution is even more important.

Opinions from healthcare professionals

A healthcare professional (doctor, pharmacist) will check three things:

If you are currently taking medication or have a health concern that needs to be addressed, consulting a doctor is still the safest course of action.

Reading studies with a critical eye

Publications available through PubMed (journals, trials, reviews) help us understand what research is exploring. The misconception to avoid: a study on a given topic does not validate a therapeutic claim. The best approach is to use research for context, to interpret conclusions with caution, and to verify the compliance of the chosen product (category, labeling, THC) rather than relying on a single slogan.

User testimonials

Testimonials bring the topic to life: daily routines, comfort, and personal experiences. They can help customers visualize the product when making a purchase, but they describe an individual experience, namely:

Conclusion: Make an informed purchase, read responsibly

CBD in Switzerland is first and foremost a matter of legislation and transparency, not a trend. Between the tetrahydrocannabinol content, the product category, and marketing communications, it is the entire regulatory framework that determines what is permitted—not just the molecule itself. Keep this rule in mind: an over-the-counter CBD product is a wellness product; as soon as a claim sounds like a therapeutic indication, ask yourself if it’s compatible with Swiss regulations, and, if you have medical concerns, consult a healthcare professional. The next logical step for those who want to go further is to look into traceability criteria and batch testing—the foundation of a mature market and sustainable purchasing.

FAQ

Is CBD legal in Switzerland?

Yes, under certain conditions. A CBD product may be sold over the counter in Switzerland if it contains less than 1% tetrahydrocannabinol and is not marketed as a medicine. The framework is established by the Narcotics Act (LDAl) and the Medicines Act (LPTh). Any product that exceeds this threshold or is marketed with unauthorized therapeutic claims is prohibited.

What is the difference between CBD and THC?

CBD (cannabidiol) and THC (tetrahydrocannabinol) are two cannabinoids derived from hemp. THC is the molecule responsible for the psychoactive effects of cannabis; CBD, on the other hand, does not produce such effects. Furthermore, their uses vary depending on the concentrations and CBD/THC ratios present in prescription formulations. In Switzerland, a hemp-based product’s compliance is determined by its market classification (cosmetics/therapeutics, etc.).

Should you consult a doctor before using CBD?

If you are currently taking medication or have a specific medical condition, then yes. CBD can interact with certain medications. Consulting with a doctor or pharmacist will help you assess the benefits versus risks based on your specific situation.

How can you tell if a CBD product is high-quality in Switzerland?

Five criteria: recent laboratory analyses (COA), traceability of the hemp, clear ingredient list, product category and labeling in line with Swiss regulations, and responsible marketing without claims of efficacy. A reputable seller provides this information transparently.

Can we talk about the "medical effects" of CBD in Switzerland?

No, not for an over-the-counter product. Swiss regulations prohibit therapeutic claims on wellness products. We can talk about usage, routine, and personal experience, but not about treatment or medical results. CBD is available for medical use, but this requires a doctor’s involvement in the care process.

Written by Anthony Lecas

On the same subject

FDA DISCLOSURE

This product is not intended for sale to persons under 18 years of age. These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your doctor before starting any new diet. Cannabidiol (CBD) is a natural constituent of the hemp plant. This product should only be used as indicated on the label. Professional medical advice should be sought before using hemp products. Consult a physician before use if you have a serious medical condition or are using prescription medication.

popup image
Discounts are yours!

Take advantage of a 10% discount and keep up to date with our offers and news by subscribing to our newsletter.

popup image
Discounts are yours!

Take advantage of a 10% discount and keep up to date with our offers and news by subscribing to our newsletter.